For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
After finishing at $4.93 in the prior trading day, Maravai LifeSciences Holdings Inc (NASDAQ: MRVI) closed at $4.94, up 0.20%. In other words, the price has increased by $0.20 from its previous closing price. On the day, 1.34 million shares were traded. MRVI stock price reached its highest trading level at $5.05 during the session, while it also had its lowest trading level at $4.71.
Ratios:
Our goal is to gain a better understanding of MRVI by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.94 and its Current Ratio is at 10.74. In the meantime, Its Debt-to-Equity ratio is 1.63 whereas as Long-Term Debt/Eq ratio is at 1.59.
On December 05, 2024, Goldman Downgraded its rating to Sell which previously was Neutral but kept the price unchanged to $4.25.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jan 31 ’25 when ORESHACK KURT sold 25,000 shares for $5.03 per share. The transaction valued at 125,750 led to the insider holds 167,618 shares of the business.
ORESHACK KURT bought 25,000 shares of MRVI for $125,750 on Jan 31 ’25. On Nov 12 ’24, another insider, DeFord John A, who serves as the Director of the company, bought 17,500 shares for $5.75 each. As a result, the insider paid 100,625 and bolstered with 70,046 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRVI now has a Market Capitalization of 1247488384 and an Enterprise Value of 1003879936. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.50 while its Price-to-Book (P/B) ratio in mrq is 2.03. Its current Enterprise Value per Revenue stands at 3.625 whereas that against EBITDA is 968.996.
Stock Price History:
The Beta on a monthly basis for MRVI is -0.08, which has changed by -0.110108316 over the last 52 weeks, in comparison to a change of 0.21926713 over the same period for the S&P500. Over the past 52 weeks, MRVI has reached a high of $11.56, while it has fallen to a 52-week low of $4.28. The 50-Day Moving Average of the stock is -7.82%, while the 200-Day Moving Average is calculated to be -34.95%.
Shares Statistics:
The stock has traded on average 2.09M shares per day over the past 3-months and 2047500 shares per day over the last 10 days, according to various share statistics. A total of 141.59M shares are outstanding, with a floating share count of 117.85M. Insiders hold about 16.91% of the company’s shares, while institutions hold 87.67% stake in the company. Shares short for MRVI as of 1736899200 were 8918685 with a Short Ratio of 4.26, compared to 1734048000 on 8292875. Therefore, it implies a Short% of Shares Outstanding of 8918685 and a Short% of Float of 7.5.
